David Johnson
Director, Caribou Biosciences, Inc.
Since Jan 1, 2022.
- Alpha ID
- alpha:person:david-johnson
- Record version
- vpublic-0:d751713988987e9331980363e24189ce, published Apr 21, 2026
- Newest evidence
- Apr 24, 2026
- Monitoring
- Not yet monitored Details
- Integrity
- Not yet signed Methodology
- Current role
- DirectorSince Jan 1, 2022
- Board seats
- 4Caribou Biosciences, Inc., Aura Biosciences, Inc.
- Committee seats
- 0None published
- Published claims
- 257 distinct sources
- Evidence records
- 160 pinned
- Source conflicts
- 0None open
Built from 7 distinct sources and 16 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.
Public-role record. Alpha publishes facts about this person's role at an organization in the public Registry, drawn from regulatory filings and company statements, and nothing about private life. Any person or agent may read it. The subject can correct, dispute, or object. How this works
DIRECTOR APPOINTED
David Johnson seat on Caribou Biosciences, Inc., effective 2022-01-01.
Monitoring
ContinuousWhat the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.
- IdentityunclaimedPublished
- EvidencecorroboratedPublished
- Evaluationnot_evaluatedPublished
- MonitoringNot yet published for this record.Not published
- AuthorityNot yet published for this record.Not published
- FreshnesscurrentPublished
Board service
EvidenceSeats held as a director, as published in the cited sources.
Caribou Biosciences, Inc. CurrentDirector, 2022 to presentOpen recordAura Biosciences, Inc. CurrentDirector, 2021 to presentOpen recordZentalis Pharmaceuticals, Inc. CurrentDirector, 2020 to presentOpen recordArthur J. Gallagher & Co. CurrentLead Independent Director, 2003 to presentOpen recordCommittee experience
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Work experience
EvidenceEducation, credentials, and certifications
EvidenceNo education, credentials, or certifications are published in this record.
No published claims
No education, credentials, or certifications are published in this record.
AI, cyber, and technology accountability
EvidenceAuthority to act
Evidence and agent registryWho may act on this authority. An agent about to transact, or one presenting itself as acting under this authority, checks these Claims first.
Compensation and holdings
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Conflicts and accountability
EvidenceOther published claims
EvidencePublished Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.
Not yet in this record
CoverageA gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.
- Only permissioned public claims and evidence are included.Only permissioned public claims and evidence are included.
- Absence of a claim is not evidence that the underlying fact is false.Absence of a claim is not evidence that the underlying fact is false.
- Public retrieval does not grant model-training or redistribution rights.Public retrieval does not grant model-training or redistribution rights.
- Private relationships and Council activity are excluded.Private relationships and Council activity are excluded.
Linked records
Same claim, both recordsEach relationship is one Claim rendered on every record it connects.
- Caribou Biosciences, Inc.Director, 2022 to presentperson:david-johnson:role:1
- Aura Biosciences, Inc.Director, 2021 to presentperson:david-johnson:role:2
- Zentalis Pharmaceuticals, Inc.Director, 2020 to presentperson:david-johnson:role:3
- Arthur J. Gallagher & Co.Lead Independent Director, 2003 to presentperson:david-johnson:role:4
- Vera Therapeutics, Inc.Chief Operating Officer, Current · dates not publishedperson:david-johnson:role:5
- Organization not publishedExecutive title: Chief Operating Officer, 2026 to end not published; Executive title: Chief Executive Officer, Dates not publishedperson:david-johnson:executive_title:18, person:david-johnson:executive_title:17
Subject and corrections
Public-role doctrineThis record exists because the subject holds a public role. The subject can claim the profile, correct, dispute, or object. Subject statements appear as their own assertion state and never overwrite the evidence.
- Basis
- Public role at an organization in the published Registry
- Sources
- 16 evidence records cited. 0 with redistribution rights.
- Never published
- Home address, family, personal contacts, health, and history unrelated to the public role
- Profile claimed
- No
- Open disputes
- 0
- Identity ownership
- unclaimed
If the subject claims the profile, their statements appear as their own assertion state, subject attested. They never overwrite the evidence.
Evidence
Authority and rights- E1SEC EDGAR. sec filing. Published Apr 24, 2026. Retrieved May 3, 2026. Cited by 6 Claims.
- E2SEC EDGAR. sec filing. Published Apr 24, 2026. Retrieved May 1, 2026. Cited by 2 Claims.
- E3sec proxy. Published Apr 24, 2026. Retrieved Apr 24, 2026. Cited by 1 Claim.
- E4SEC EDGAR. sec filing. Published Apr 20, 2026. Retrieved May 15, 2026. Cited by 2 Claims.
- E5sec proxy. Published Apr 20, 2026. Retrieved Apr 24, 2026. Cited by 1 Claim.
- E6SEC EDGAR. sec filing. Published Apr 9, 2026. Retrieved May 5, 2026. Cited by 6 Claims.
- E7sec def 14a. Published Apr 9, 2026. Retrieved Sep 14, 2026. Cited by 1 Claim.
- E8SEC EDGAR. sec filing. Published Mar 23, 2026. Retrieved May 3, 2026. Cited by 6 Claims.
- E9sec proxy. Published Mar 23, 2026. Retrieved Mar 25, 2026. Cited by 1 Claim.
- E10SEC EDGAR. sec filing. Published Nov 10, 2025. Retrieved May 15, 2026. Cited by 2 Claims.
- E11SEC EDGAR. sec filing. Published Apr 30, 2025. Retrieved May 16, 2026. Cited by 7 Claims.
- E12sec proxy. Published Apr 30, 2025. Retrieved Apr 28, 2026. Cited by 1 Claim.
- E13public source. Cited by 1 Claim.
- E14public source. Cited by 1 Claim.
- E15public source. Cited by 1 Claim.
- E16public source. Cited by 1 Claim.
What changed in version public-0:d751713988987e9331980363e24189ce
vpublic-0:d751713988987e9331980363e24189ce published Apr 21, 2026- David Johnson seat on Caribou Biosciences, Inc., effective 2022-01-01.
- David Johnson seat on Aura Biosciences, Inc., effective 2021-01-01.
- David Johnson seat on Zentalis Pharmaceuticals, Inc., effective 2020-01-01.
- David Johnson seat on Arthur J. Gallagher & Co., effective 2003-01-01.

